Literature DB >> 8662709

gp130 transducing receptor cross-linking is sufficient to induce interleukin-6 type responses.

M Fourcin1, S Chevalier, C Guillet, O Robledo, J Froger, A Pouplard-Barthelaix, H Gascan.   

Abstract

gP130 transducing receptor is involved in the formation of high affinity receptors for the cytokines of the interleukin-6 (IL-6) family. Recruitment of gp130 by IL-6 associated to its receptor leads to the dimerization of the transducing component. In the present study we did characterize the B-S12 monoclonal antibody raised against gp130 and able to elicit IL-6 type biological activities. B-S12 antibody triggered strongly the proliferation of TF1 and XGI hematopoietic cell lines and was able to increase the synthesis of acute phase proteins in HepG2 hepatoma cell line. B-S12 also behaved as a synergistic factor with granulocyte-macrophage colony-stimulating factor for both proliferation and differentiation of CD34-positive hematopoietic cell progenitors. By using a symmetric enzyme-linked immunosorbent assay, allowing the detection of dimeric forms of soluble gp130, we found that addition of B-S12 to gp130 led to its dimerization. Analysis of the tyrosine phosphorylation events in gp130 and Jak kinase family members revealed that B-S12 quickly induced the phosphorylation of gp130 in a neural derived cell line, and that Jak1 and Jak2 were also recruited. In conclusion, we show that gp130 cross-linking with the B-S12 monoclonal antibody was sufficient to generate functional IL-6 type responses in hematopoietic, neural, and hepatic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662709     DOI: 10.1074/jbc.271.20.11756

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

Authors:  Russell N Johnson; Pavla Kopečková; Jindřich Kopeček
Journal:  Biomacromolecules       Date:  2012-02-21       Impact factor: 6.988

Review 2.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

3.  Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.

Authors:  A Hammacher; J Wijdenes; D J Hilton; N A Nicola; R J Simpson; J E Layton
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

4.  Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.

Authors:  Te-Wei Chu; Jindřich Kopeček
Journal:  Biomater Sci       Date:  2015-07       Impact factor: 6.843

5.  Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins.

Authors:  K Althoff; J Müllberg; D Aasland; N Voltz; K Kallen; J Grötzinger; S Rose-John
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

6.  Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.

Authors:  Libin Zhang; Yixin Fang; Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2016-12-24       Impact factor: 9.776

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.